• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴酚丁胺试验评估的收缩储备可识别心脏再同步治疗的超强反应者。

Contractile reserve assessed by dobutamine test identifies super-responders to cardiac resynchronization therapy.

机构信息

Institute for Cardiovascular Diseases Dedinje, Belgrade, Serbia.

Pacemaker Center, Clinical Center of Serbia, Belgrade, Serbia.

出版信息

Arch Med Sci. 2014 Aug 29;10(4):684-91. doi: 10.5114/aoms.2014.40790.

DOI:10.5114/aoms.2014.40790
PMID:25276151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4175763/
Abstract

INTRODUCTION

In this study, we sought to determine whether myocardial contractile reserve (CR) assessed by dobutamine stress echocardiography (DSE) can identify patients who experience nearly complete normalization of left ventricular (LV) function after the implantation of a cardiac resynchronization therapy (CRT) pacemaker.

MATERIAL AND METHODS

The study group consisted of 55 consecutive patients with non-ischemic dilated cardiomyopathy, LV ejection fraction (LVEF) < 35%, and prolonged QRS complex duration, who were scheduled for CRT pacemaker implantation. The DSE (20 µg/kg/min) was performed in all patients. The CR assessment was based on a change in the wall motion score index (ΔWMSI) and ΔLVEF during DSE. Super-response was defined as an increase in LVEF to > 50% and reduction in left ventricular end-systolic dimension to < 40 mm 12 months following the CRT implantation.

RESULTS

A total of 7 patients (12.7%) were identified as super-responders to CRT. When compared to non-super-responders, these patients had significantly higher values of the dobutamine-induced change in ΔWMSI (1.031 ±0.120 vs. 0.49 ±0.371, p < 0.01), and ΔEF (17.9 ±2.2 vs. 8.8 ±6.2, p < 0.01). Receiver operating characteristic analysis showed that dobutamine-induced changes in ΔWMSI ≥ 0.7 and ≥ 14% for ΔEF are the best discriminators for a super-response. Patients with ΔWMSI ≥ 0.7 and ΔEF ≥ 14% are significantly less often hospitalized (p < 0.01) for worsening of heart failure during 28.5 ±3.0 months of the follow-up.

CONCLUSIONS

Contractile reserve assessed by DSE can identify patients with dilated cardiomyopathy who are likely to experience near normalization of LV function following CRT.

摘要

引言

本研究旨在探讨多巴酚丁胺负荷超声心动图(DSE)评估的心肌收缩储备(CR)是否能识别出接受心脏再同步治疗(CRT)起搏器植入后左心室(LV)功能几乎完全正常化的患者。

材料与方法

研究组纳入了 55 例非缺血性扩张型心肌病、LV 射血分数(LVEF)<35%且 QRS 波群持续时间延长的连续患者,这些患者均计划植入 CRT 起搏器。所有患者均进行 DSE(20μg/kg/min)检查。CR 的评估基于 DSE 期间的室壁运动评分指数(WMSI)变化和ΔLVEF。超反应定义为 LVEF 增加>50%,左心室收缩末期内径减小<40mm,在 CRT 植入后 12 个月。

结果

共有 7 例(12.7%)患者被确定为 CRT 的超反应者。与非超反应者相比,这些患者的多巴酚丁胺诱导的ΔWMSI变化值显著更高(1.031±0.120 比 0.49±0.371,p<0.01)和ΔEF(17.9±2.2 比 8.8±6.2,p<0.01)。受试者工作特征曲线分析显示,多巴酚丁胺诱导的ΔWMSI变化≥0.7 和 ΔEF 变化≥14%是超反应的最佳预测因子。ΔWMSI≥0.7 和 ΔEF≥14%的患者在 28.5±3.0 个月的随访期间因心力衰竭恶化而住院的情况显著减少(p<0.01)。

结论

DSE 评估的收缩储备可识别出接受 CRT 后 LV 功能可能接近正常化的扩张型心肌病患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48a/4175763/aee13024e379/AMS-10-22304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48a/4175763/34f92ea3cb19/AMS-10-22304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48a/4175763/f2a985b851b8/AMS-10-22304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48a/4175763/dc1de3357acd/AMS-10-22304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48a/4175763/aee13024e379/AMS-10-22304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48a/4175763/34f92ea3cb19/AMS-10-22304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48a/4175763/f2a985b851b8/AMS-10-22304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48a/4175763/dc1de3357acd/AMS-10-22304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48a/4175763/aee13024e379/AMS-10-22304-g004.jpg

相似文献

1
Contractile reserve assessed by dobutamine test identifies super-responders to cardiac resynchronization therapy.多巴酚丁胺试验评估的收缩储备可识别心脏再同步治疗的超强反应者。
Arch Med Sci. 2014 Aug 29;10(4):684-91. doi: 10.5114/aoms.2014.40790.
2
Global myocardial contractile reserve assessed by high-dose dobutamine stress echocardiography predicts response to the cardiac resynchronization therapy.通过高剂量多巴酚丁胺负荷超声心动图评估的整体心肌收缩储备可预测心脏再同步治疗的反应。
Echocardiography. 2015 Mar;32(3):490-5. doi: 10.1111/echo.12694. Epub 2014 Jul 24.
3
Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy.心肌收缩储备可预测心脏再同步治疗后左心室功能的改善。
Am Heart J. 2007 Dec;154(6):1160-5. doi: 10.1016/j.ahj.2007.07.035. Epub 2007 Sep 14.
4
Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.通过应变超声心动图评估的局部心肌收缩储备以及对心脏再同步治疗的反应。
Cardiol J. 2014;21(5):524-31. doi: 10.5603/CJ.a2014.0003. Epub 2014 Feb 14.
5
Dynamic relationship of left-ventricular dyssynchrony and contractile reserve in patients undergoing cardiac resynchronization therapy.心脏再同步治疗患者左心室收缩不同步与收缩储备的动态关系。
Eur Heart J. 2014 Jan;35(1):48-55. doi: 10.1093/eurheartj/eht294. Epub 2013 Aug 4.
6
Contractile reserve assessed using dobutamine echocardiography predicts left ventricular reverse remodeling after cardiac resynchronization therapy: prospective validation in patients with left ventricular dyssynchrony.使用多巴酚丁胺超声心动图评估的收缩储备可预测心脏再同步治疗后左心室逆向重构:左心室不同步患者的前瞻性验证
Echocardiography. 2010 Jul;27(6):668-76. doi: 10.1111/j.1540-8175.2009.01106.x. Epub 2010 Mar 25.
7
Inotropic contractile reserve can risk-stratify patients with HIV cardiomyopathy: a dobutamine stress echocardiography study.正性肌力收缩储备可对 HIV 心肌病患者进行风险分层:多巴酚丁胺负荷超声心动图研究。
JACC Cardiovasc Imaging. 2011 Dec;4(12):1231-8. doi: 10.1016/j.jcmg.2011.09.012.
8
Presence of left ventricular contractile reserve predicts midterm response to cardiac resynchronization therapy--results from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) trial.左心室收缩储备的存在可预测心脏再同步化治疗的中期反应——来自低剂量多巴酚丁胺负荷超声心动图试验在心脏再同步化治疗(LODO-CRT)试验中的结果。
Heart Rhythm. 2010 Nov;7(11):1600-5. doi: 10.1016/j.hrthm.2010.07.036. Epub 2010 Aug 3.
9
The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.心脏再同步治疗对扩张型心肌病和心力衰竭患者左心室功能、心肌能量代谢及代谢储备的影响。
J Am Coll Cardiol. 2004 Mar 17;43(6):1027-33. doi: 10.1016/j.jacc.2003.10.044.
10
Low-dose dobutamine stress echocardiography to assess left ventricular contractile reserve for cardiac resynchronization therapy: data from the Low-Dose Dobutamine Stress Echocardiography to Predict Cardiac Resynchronization Therapy Response (LODO-CRT) trial.低剂量多巴酚丁胺负荷超声心动图评估心脏再同步治疗的左心室收缩储备:来自低剂量多巴酚丁胺负荷超声心动图预测心脏再同步治疗反应(LODO-CRT)试验的数据。
Congest Heart Fail. 2010 May-Jun;16(3):104-10. doi: 10.1111/j.1751-7133.2010.00141.x.

引用本文的文献

1
The Utility of Low-Dose-Dobutamine Stress Echocardiography in Patients with Heart Failure with Reduced Ejection Fraction: An Update.低剂量多巴酚丁胺负荷超声心动图在射血分数降低的心力衰竭患者中的应用:最新进展
Diagnostics (Basel). 2023 Sep 12;13(18):2920. doi: 10.3390/diagnostics13182920.
2
Left atrial volume index predicts response to cardiac resynchronisation therapy: a systematic review and meta-analysis.左心房容积指数可预测心脏再同步治疗的反应:一项系统评价和荟萃分析。
Arch Med Sci. 2020 Jan 10;18(4):930-938. doi: 10.5114/aoms.2019.91511. eCollection 2022.
3
Advances in Cardiac Resynchronization Therapy.

本文引用的文献

1
Right atrial appendage pacing in cardiac resynchronization therapy - haemodynamic consequences of interatrial conduction delay.右心耳起搏在心脏再同步治疗中的应用 - 房间传导延迟的血液动力学后果。
Arch Med Sci. 2011 Aug;7(4):728-31. doi: 10.5114/aoms.2011.24146. Epub 2011 Sep 2.
2
A new baseline scoring system may help to predict response to cardiac resynchronization therapy.一种新的基线评分系统可能有助于预测心脏再同步治疗的反应。
Arch Med Sci. 2011 Aug;7(4):627-33. doi: 10.5114/aoms.2011.24132. Epub 2011 Sep 2.
3
Identification and characterization of super-responders after cardiac resynchronization therapy.
心脏再同步治疗的进展
J Innov Card Rhythm Manag. 2019 Jun 15;10(6):3681-3693. doi: 10.19102/icrm.2019.100604. eCollection 2019 Jun.
4
Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy.接受心脏再同步治疗的慢性心力衰竭患者的白细胞介素-6信号通路
Arch Med Sci. 2017 Aug;13(5):1069-1077. doi: 10.5114/aoms.2016.58635. Epub 2016 Mar 17.
5
Current role of echocardiography in cardiac resynchronization therapy.超声心动图在心脏再同步治疗中的作用。
Heart Fail Rev. 2017 Nov;22(6):699-722. doi: 10.1007/s10741-017-9636-1.
6
Variability of longitudinal strain in left ventricular segments supplied by non-stenosed coronary artery: insights from speckle tracking analysis of dobutamine stress echocardiograms in patients with high coronary risk profile.非狭窄冠状动脉供血的左心室节段纵向应变的变异性:来自高冠状动脉风险患者多巴酚丁胺负荷超声心动图斑点追踪分析的见解
Arch Med Sci. 2017 Feb 1;13(1):82-92. doi: 10.5114/aoms.2016.60603. Epub 2016 Jun 14.
7
Comparison of sublingual isosorbide dinitrate and Valsalva maneuver for detection of obstruction in hypertrophic cardiomyopathy.舌下含服硝酸异山梨酯与瓦尔萨尔瓦动作在肥厚型心肌病梗阻检测中的比较。
Arch Med Sci. 2015 Aug 12;11(4):751-5. doi: 10.5114/aoms.2015.47096. Epub 2015 Jan 14.
8
Principles of transthoracic echocardiographic evaluation.经胸超声心动图评估原则。
Nat Rev Cardiol. 2015 Jul;12(7):426-40. doi: 10.1038/nrcardio.2015.57. Epub 2015 Apr 28.
心脏再同步治疗后超级应答者的识别和特征描述。
Am J Cardiol. 2010 May 1;105(9):1327-35. doi: 10.1016/j.amjcard.2009.12.058.
4
Characterization of super-response to cardiac resynchronization therapy.超反应性对心脏再同步治疗的特征描述。
Heart Rhythm. 2010 Jul;7(7):885-9. doi: 10.1016/j.hrthm.2010.04.005. Epub 2010 Apr 8.
5
Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.心脏再同步治疗可使纽约心脏协会心功能I/II级心力衰竭患者出现显著的结构和功能逆向重构。
Circulation. 2009 Nov 10;120(19):1858-65. doi: 10.1161/CIRCULATIONAHA.108.818724. Epub 2009 Oct 26.
6
Cardiac-resynchronization therapy for the prevention of heart-failure events.心脏再同步治疗预防心力衰竭事件
N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.
7
Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy.运动期间的心肌收缩储备可预测心脏再同步治疗后左心室逆向重构。
Eur J Echocardiogr. 2009 Jul;10(5):663-8. doi: 10.1093/ejechocard/jep033. Epub 2009 Apr 7.
8
Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography.在负荷超声心动图检查中通过收缩储备识别心脏再同步治疗的反应者。
Eur J Heart Fail. 2009 May;11(5):489-96. doi: 10.1093/eurjhf/hfp039. Epub 2009 Mar 26.
9
Low-dose dobutamine stress echo to quantify the degree of remodelling after cardiac resynchronization therapy.低剂量多巴酚丁胺负荷超声心动图用于量化心脏再同步治疗后的重塑程度。
Eur Heart J. 2009 Apr;30(8):950-8. doi: 10.1093/eurheartj/ehp050. Epub 2009 Mar 5.
10
Identification of 'super-responders' to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry.心脏再同步治疗“超级反应者”的识别:症状持续时间和左心室几何形状的重要性。
Europace. 2009 Mar;11(3):343-9. doi: 10.1093/europace/eup038.